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Background: Ginsenoside Rg1 is a class of steroid glycoside and triterpene saponin in Panax ginseng.
Many studies suggest that Rg1 suppresses adipocyte differentiation in 3T3-L1. However, the detail mo-
lecular mechanism of Rg1 on adipogenesis in 3T3-L1 is still not fully understood.
Methods: 3T3-L1 preadipocyte was used to evaluate the effect of Rg1 on adipocyte development in the
differentiation in a stage-dependent manner in vitro. Oil Red O staining and Nile red staining were
conducted to measure intracellular lipid accumulation and superoxide production, respectively. We
analyzed the protein expression using Western blot in vitro. The zebraﬁsh model was used to investigate
whether Rg1 suppresses the early stage of fat accumulation in vivo.
Results: Rg1 decreased lipid accumulation in early-stage differentiation of 3T3-L1 compared with in-
termediate and later stages of adipocyte differentiation. Rg1 dramatically increased CAAT/enhancer
binding protein (C/EBP) homologous protein-10 (CHOP10) and subsequently reduced the C/EBPb tran-
scriptional activity that prohibited the initiation of adipogenic marker expression as well as triglyceride
synthase. Rg1 decreased the expression of extracellular signal-regulated kinase 1/2 and glycogen syn-
thase kinase 3b, which are also essential for stimulating the expression of CEBPb. Rg1 also reduced
reactive oxygen species production because of the downregulated protein level of nicotinamide adenine
dinucleotide phosphate hydrogen (NADPH) oxidase 4 (NOX4). While Rg1 increased the endogenous
antioxidant enzymes, it also dramatically decreased the accumulation of lipid and triglyceride in high fat
diet-induced obese zebraﬁsh.
Conclusion: We demonstrated that Rg1 suppresses early-stage differentiation via the activation of
CHOP10 and attenuates fat accumulation in vivo. These results indicate that Rg1 might have the potential
to reduce body fat accumulation in the early stage of obesity.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
High fat diet (HFD)-induced obesity is a serious public health
problem worldwide, and is an underlying factor of metabolic syn-
drome as well as multiple postmodern noncommunicable diseases
[1]. Body fat accumulation is caused by different of processes
including hyperplasia and hypertrophic in obesity [2]. Hyperplasia
and hypertrophic adipocyte are induced as a result of adipogenesis,preadipocyte.
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work.
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d/4.0/).which is the process of adipocyte differentiation for cell prolifera-
tion and lipid accumulation [3]. During the mitotic clonal expan-
sion phase, which is the early stage of adipogenesis in adipocyte,
CAAT/enhancer binding protein b (C/EBPb; which starts to coordi-
nate the multiple transcriptional regulation by turning on major
adipogenic factors), C/EBPa, and peroxisome proliferator-activated
receptor g (PPARg) are expressed [4,5]. Moreover, adipogenic fac-
tors markedly upregulates the adipocyte protein 2 (aP2) andScience, CHA University, CHA BioComplex, 335 Pangyo-ro, Bundang-gu, Seongnam-
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
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acyltransferase (LPAT), Lipin1, and diacylglycerolacyltransferase 1
(DGAT1) during the late stage of adipogenesis [6,7].
The development of adipocyte is also associated with an
oxidative stress in obesity [8]. The abundance of reactive oxygen
species (ROS), which is generated by nicotinamide adenine dinu-
cleotide phosphate hydrogen (NADPH) oxidase 4 (NOX4) during
adipogenesis, leads to increased cellular damage and insulin
resistance [9,10]. By contrast, the endogenous antioxidant enzymes,
such as the enzyme superoxide dismutase 1 (SOD1), SOD2, catalase
(CAT) glutathione peroxidase (GPx), and glutathione reductase
(GR), have been reported to lead to low levels of enzymes in obese
mice [11].
Recently, it has been reported that ROS is important in stimu-
lating the mitotic clonal expansion (MCE) during adipogenesis by
increasing the C/EBPb activity [12]. Moreover, C/EBP homologous
protein-10 (CHOP10) functions as a negative regulator of C/EBPb in
the early stage of adipogenesis [13]. Mitogen-activated protein ki-
nases (MAPKs), which include three groupsdextracellular signal-
regulated kinases (ERK), c-Jun amino-terminal kinases (JNK), and
p38 MAPK, are intracellular signaling pathways that play a pivotal
role in many essential cellular processes such as proliferation and
differentiation [14]. The phosphorylation of ERK regulates cell
proliferation and is required to induce the expression of C/EBPb for
initiating the differentiation process in the early stage of adipo-
genesis [15,16]. Moreover, phosphorylation of C/EBPb at a
consensus ERK/glycogen synthase kinase 3b (GSK3b) site is
required for the activation of primary adipogenic factor expression
including C/EBPa, PPARg, and aP2 [17]. Therefore, regulation of the
early stage of marker C/EBPb is important to suppress the devel-
opment of adipocyte in obese individuals.
The higher intake of fruits and herbs in comparison with HFD is
correlated with a dramatically decreased risk of obesity and
obesity-associated noncommunicable diseases [18]. These fruits
and herbs contain numerous bioactive compounds that have the
potential to be used as therapeutic agents for noncommunicable
diseases including obesity [19,20].
Panax ginseng is a traditional herbal medicine used around the
world. Ginsenoside is an active component of P. ginseng and has
been elucidated to have anti-inﬂammatory, antioxidant, anticancer,
and antidiabetes effects [21e23]. Rg1 is a triterpene saponin and
one of the principal active compounds extracted from P. ginseng.
Recently, we and other groups reported that Rg1 stimulates glucose
uptake, mitigates oxidative stress in rat skeletal muscles and sup-
presses triglyceride accumulation in 3T3-L1 [24e26]. However, the
underlying contribution of Rg1 to the early stage of adipogenesis
and ROS promotion remains unclear.
Thus, we investigated how Rg1 regulates the aforementioned
gene expression including adipocyte differentiation makers, anti-
oxidant enzymes, CHOP10, and GSK3b in the development of 3T3-
L1 in a stage-dependent manner. Moreover, we have evaluated the
effect of Rg1 on lipid and triglyceride accumulation in the HFD-
induced obese zebraﬁsh model.
2. Materials and methods
2.1. Materials
Ginsenoside Rg1 (95% purity) was purchased from ChengDu
Biopurify Phytochemicals Ltd. (Biopurify, ChengDu, China). 3T3-L1
preadipocyte was purchased from the ATCC (CL-173; American
Type Culture Collection, Manassas, VA, USA). Dulbecco’s modiﬁed
Eagle’s medium (DMEM), bovine calf serum (BCS), fetal bovine
serum (FBS), penicillinestreptomycin (P/S), phosphate-buffered
saline (PBS), and trypsineEDTA were purchased from Gibco(Gaithersburg, MD, USA). Dexamethasone (DEX), 3-isobutyl-1-
methylxanthine (IBMX), insulin, Oil Red O, nitroblue tetrazolium
(NBT), and N-acetyl cysteine (NAC) were purchased from Sigma (St.
Louis, MO, USA). Peroxide-sensitive ﬂuorophore 2,70-dichlor-
odihydroﬂuoresceindiacetate (DCF-DA) was purchased from Cell
Biolabs (San Diego, CA, USA). 2,3-Bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carbox-anilide (XTT) reagent and
N-methyl dibenzopyrazine methyl sulfate (PMS) were purchased
from Welgene (Gyeongsan, South Korea). Unless noted otherwise,
all chemicals were also purchased from Sigma Chemical Co.
Antibodies speciﬁc for aP2, JNK, p38MAPK, phospho-p38MAPK
(Thr180/Tyr182), ERK1/2, and GPx were purchased from Cell
Signaling Technology (Danvers, MA, USA). Antibodies against
CHOP10, C/EBPb, C/EBPa, PPARg, LPAT, Lipin1, DGAT1, phospho-
ERK1/2 (Thr202/Tyr204), phospho-JNK (Thr183/Tyr185), phos-
pho-GSK3b, GSK3b, GR, SOD1, CAT, NOX4, and b-actin were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
2.2. Cell culture
3T3-L1 preadipocyte were cultured in DMEM medium con-
taining 3.7 g/L sodium bicarbonate, 1% P/S, and 10% BCS at 37C in
5% CO2. Two-day postconﬂuent cells were induced to differentiate
via treatment with 10% FBS and MDI hormone cocktail (0.5mM
IBMX, 1.0mM DEX, and 5 mg/mL insulin; Day 0). The medium was
replaced with DMEM containing 5 mg/mL insulin and 10% FBS for a
further 2 d (Day 2). This medium was then replaced with fresh
DMEM containing 10% FBS every other day until the indicated time
point (Days 6e8). Next, 25mM, 50 mM, and 100mM Rg1 and 5mM
NAC were dissolved in DMSO. The ﬁnal concentration of DMSOwas
0.25% in all experiments.
2.3. Cell viability assay
3T3-L1 preadipocyte (1  104 cells/well) in 96-well plates were
treated with Rg1 (0mM, 25mM, 50mM, 100mM, and 200mM) and
incubated for 24 h. XTT reagent and PMS were added to the culture
and incubated for 2 h at 37C. Soluble formazan salt in the medium
was measured by enzyme-linked immunosorbent assay (ELISA)
reader Wallac 140 victor (Perkin-Elmer, Boston, MA, USA) at
450 nm against 690 nm.
2.4. Oil Red O staining
Differentiated 3T3-L1 cells, which were washed with PBS, were
ﬁxed with 10% formaldehyde at 4C for 1 h. After washing with PBS,
the ﬁxed cells were stained with 0.5% Oil Red O in 60:40 (v/v) Oil
Red O/H2O for 2 h at room temperature, and then washed three
times with water. Lipid accumulation was observed with an
inverted light Olympus CKX41microscope (Olympus, Tokyo, Japan).
Then, 100% isopropanol was used to elute Oil Red O dye, and the
absorbance at 490 nm was determined using ELISA reader Wallac
140 victor (Perkin-Elmer).
2.5. NBT assay
3T3-L1 preadipocytes were grown to conﬂuence and induced to
differentiate into adipocytes, as previously described. Production of
ROSwas detected via an NBTassay. Nitrobluetetrazolium is reduced
by ROS to a dark blue, insoluble form of NBT called formazan [11].
On Day 8 after induction, the cells were incubated for 90 min in PBS
containing 0.2% NBT. Formazan was dissolved in 100% acetic acid,
and the absorbance was determined using the ELISA reader Wallac
140 victor (Perkin-Elmer) at 570 nm.
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3T3-L1 preadipocyte (1  104 cells/well) in 96-well plates were
differentiated for 24 h. Differentiated cells were detected by 20mM
DCF-DA. After incubation for 30 min in 5% CO2 incubator at 37C,
3T3-L1 cells were washed with PBS, and absorbance was deter-
mined by ELISA reader Wallac 140 victor (Perkin-Elmer) at 480 nm
against 530 nm.
2.7. Western blotting
Cells were harvested by lysis buffer containing protease in-
hibitors and phosphatase inhibitor cocktail II, III. Protein extracts
(25 mg) were separated via sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and transferred to a polyvinyl diﬂuoride (PVDF)
membrane. The membranes were blocked with 5% nonfat dry milk
and immunoblotted with primary antibodies speciﬁc for indicated
proteins for overnight. Secondary antibodies conjugated with
horseradish peroxidase (1:5,000) were applied for 4 h. The bands
were visualized by enhanced chemiluminescence, and proteins
were detected with LAS image software (Fuji, New York, NY, USA).
2.8. Animal husbandry
Wild-type adult zebraﬁsh (Danio rerio) were initially obtained
from Chungnam National University (Daejeon, South Korea). Em-
bryos and larvae were obtained by natural mating and raised in
embryo water containing Sea salts (Sigma) of 60 mg/mL until 5
d postfertilization (5 dpf). Then, larvaeweremaintained in 100-mm
plate at a density of about 20 larvae per 100 mL, and fed hard-
boiled egg yolk as an HFD once a day in the presence or absence
of indicated compounds for 12e15 d (17e20 dpf). Zebraﬁsh larvae
used for imaging analysis were starved for 24 h to empty the
digestive tract prior to Nile red staining.
2.9. Nile red staining, ﬂuorescence imaging
The stock solution (1.25 mg/mL) of Nile red (Invitrogen N-1142)
was prepared in acetone and stored in the dark at 20C. For
staining of ﬁsh, stock solutionwas diluted to 50 ng/mL in egg water
and incubated for 5e10 min at 28C in the dark. Fishes were
washed with distilled water three times and anesthetized with a
few drops of tricaine stock solution (Sigma; 4 mg/mL, pH 7.0).
Fishes were mounted in 3% methylcellulose, and Nile red stainingFig. 1. Structure of Rg1 and its cytotoxicity in 3T3-L1 preadipocyte. (A) Chemical structure of
and 200mM Rg1, and 5mM NAC for 24 h. Cell viability was measured by XTT assay at 450 nm
one-way ANOVA and Duncan’s multiple range test. Values with different superscript letters
XTT, 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carbox-anilide.was imaged under ECLIPSE E600 (Nikon, Tokyo, Japan) ﬂuorescence
microscope, which was used for green ﬂuorescent imaging.
2.10. Quantiﬁcation of triglycerides
Triglyceride was measured using a total triglyceride assay kit
(Zen-Bio, Research Triangle Park, NC, USA). Cells and zebraﬁsh were
washed with phosphate-buffered saline to remove residual me-
dium, and the cells were lysed with lysis buffer. Triglyceride was
digested with Reagent B for 2 h to release hydrolyzed glycerols into
the buffer. Diluted hydrolysates were incubated with Reagent A
containing peroxidase to produce quinoneimine dye, which shows
an absorbance maximum in spectrophotometric detection at
540 nm.
2.11. Statistical analysis
All values are expressed as mean standard deviation values. All
datawere obtained at least in triplicate or hexaplicate experiments.
Differences among multiple groups were determined using one-
way analysis of variance followed by Duncan’s multiple range test
using the SAS 9.0 software (SAS Institute, NC, USA). A p value< 0.05
was considered statistically signiﬁcant.
3. Results
3.1. Rg1 attenuates lipid accumulation via regulation of C/EBPa,
PPARg, and aP2 in 3T3-L1
Ginsenoside Rg1 is an active component of ginseng as tri-
terpenoid saponins, as shown in Fig. 1A. We performed the XTT
assay to analyze the viability of 3T3-L1 cells treated with Rg1 for
24 h. As shown in Fig. 1B, Rg1 at 200mM in 3T3-L1 was found to be
toxic to cells. Therefore, the concentrations of 25mM, 50mM, and
100mM Rg1 were selected for further investigation. Moreover, we
measured the cytotoxicity of NAC, which has been used as an in-
hibitor of adipocyte differentiation in 3T3-L1. The concentration of
5mM NAC was not found to be toxic to cells compared with control.
We investigated the effects of Rg1 on lipid accumulation in 3T3-
L1 cells. Rg1 decreased lipid accumulation in a dose-dependent
manner during differentiation, as shown in Fig. 2A. Notably, the
concentration of 100mM Rg1 showed a great reduction effect on
lipid accumulation (more than 70%) compared with control. NAC,
used as a positive control, strongly decreases lipid accumulation.Rg1 (C42H72O14). (B) 3T3-L1 preadipocyte were treated with 0mM, 25mM, 50mM, 100mM,
and 690 nm. The experiment was performed in hexaplicates. Results were analyzed by
are signiﬁcantly different, p < 0.05. ANOVA, analysis of variance; NAC, N-acetyl cystein;
Fig. 2. Rg1 downregulates adipogenic factors and triglyceride synthetic enzymes during adipogenesis in 3T3-L1 cells. (A) Lipid accumulation was measured with Oil Red O assay in
3T3-L1 cells differentiated with the presence or absence of 25mM, 50mM,100mM Rg1/5mMNAC during 8 d and determined at 490 nm. Results were analyzed by one-way ANOVA and
Duncan’s multiple range test. The experiment was performed in hexaplicates. Values with different superscript letters are signiﬁcantly different, p < 0.05. (B) Cell lysates differ-
entiated during 8 d were subjected to Western blot to analyze C/EBPa, PPARg, and aP2 protein expression. The experiment was performed in triplicate. (C) Cell lysates differentiated
during 8 d were subjected to Western blot to analyze LPAT, Lipin1, and DGAT1 protein expression. The experiment was performed in triplicate. ANOVA, analysis of variance; C/EBPa,
CAAT/enhancer binding protein a; CON, control; NAC, N-acetyl cystein; ND, nondifferentiated preadipocyte; PPARg, peroxisome proliferator-activated receptor g.
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including C/EBPa, PPARg, and aP2 in a dose-dependent manner, as
shown in Fig. 2B and Figs. S1AeS1C.
3.2. Rg1 downregulates triglyceride synthesis enzymes during
differentiation in 3T3-L1
Lipid droplet in adipose tissue is mainly composed of tri-
glycerides and sterol esters. A lack of triglyceride synthesis is
known to block adipocyte differentiation [27]. The key enzymes for
lipogenesis including LPAT, Lipin1, and DGAT1 catalyze triglyceride
synthesis in adipose tissue [28e30].
To gain a better understanding of the molecular mechanism
underlying the inhibition of triglyceride effect of Rg1, we used
Western blotting to analyze the protein expression of LPAT, Lipin1,
and DGAT1. Consistent with the increase in the adipogenic differ-
entiation markers, the expression of key enzymes in triglyceride
synthesis including LPAT, Lipin1, and DGAT increased substantially
in control, as shown in Fig. 2C and Figs. S1DeS1F. By contrast, Rg1
dramatically derepressed the expression of LPAT, Lipin1, and DGAT1
in a dose-dependent manner compared to values in the cell
without Rg1 treatment.
In particular, Lipin1 induces the expression of PPARg via direct
physical interaction and leads to elevated aP2 expression in the late
stage of adipocyte differentiation [7,31]. These lines of evidence
prompted us to hypothesize that Rg1 may be a powerful reducer of
adipogenesis at the early stage of adipocyte differentiation.
3.3. Rg1 preferentially suppresses lipid accumulation and ROS
production in early stage of adipogenesis
Next, to test our hypothesis, 3T3-L1 preadipocytes were stimu-
lated to differentiation with MDI in the presence or absence of Rg1in the early stage (Days 0e2), intermediate stage (Days 2e4), and
later stage (Days 4e6) of adipocyte differentiation, as shown in
Fig. 3A. We found that Rg1 decreased the differentiation from
preadipocyte into adipocyte in a stage-dependent manner, as
shown in Fig. 3B. Compared with cells treated with 100mM Rg1 in
the intermediate stage (Days 2e4) and later stage (Days 4e6) of
adipocyte differentiation, the optical density (OD) values of Oil Red
O in the cells treated with 100mM Rg1 in the early stage (Days 0e2)
of adipocyte differentiation signiﬁcantly decreased by approxi-
mately 35.3% and 46.3%, respectively.
Moreover, the product of ROS is required to initiate preadipocyte
differentiation into adipocyte [32]. Again, to determine whether
Rg1modulates early stage-speciﬁc adipocyte differentiation in 3T3-
L1, the generation of intracellular ROS was measured using the NBT
assay. Consistent with the decrease in intracellular lipid accumu-
lation, Rg1 at 100mM signiﬁcantly decreased ROS production in the
early stage (Days 0e2) of adipocyte differentiation compared to
cells treated with 100mM Rg1 in the intermediate stage (Days 2e4)
and later stage (Days 4e6) of adipocyte differentiation, as shown in
Fig. 3C.
To assess the changes in the activity of ROS-related antioxidant
enzymes at an early stage of adipogenesis with MDI in the absence
or presence of 25mM, 50mM, and 100mM Rg1, the expression of GPx,
GR, SOD1, CAT, and NOX4 was determined as an indicator of ROS by
Western blotting. As shown in Fig. 4B and Figs. S2AeS2E, Rg1 was
associated with a signiﬁcant enhancer of the activities of the pro-
tective endogenous enzymes GPx, GR, and SOD1 at an early stage of
adipogenesis, even at the lowest dose. The measured protein
expression in the cells with the presence of 25mM, 50mM, and 100
mM Rg1 signiﬁcantly increased by 37.2%, 42.9%, and 72.3% for GPx,
and 62.9%, 73.1%, and 99.3% for GR, and 35.9%, 53.2%, and 75.6% for
SOD1, respectively. Notably, CAT activity was increased in a dose-
dependent manner. Loss of NOX4 suppresses ROS generation and
Fig. 3. Rg1 preferentially suppresses lipid accumulation and ROS production at an early stage of adipogenesis. (A) Preadipocyte differentiation was initiated by IBMX, dexa-
methasone, and insulin in the presence or absence of 5mM NAC or 100mM Rg1 for the indicated tables. (B) Lipid accumulation was evaluated by Oil Red O assay in 3T3-L1 cells
differentiated in the presence or absence of 5mM NAC/100mM Rg1 for the indicated tables and determined at 490 nm. Results were analyzed by one-way ANOVA and Duncan’s
multiple range test. These data were measured as the standard deviation of hexaplicates. Values with different superscript letters are signiﬁcantly different, p < 0.05. (C) ROS
production was subjected to NBT assay in cells differentiated during 6 d for the indicated tables and determined at 570 nm. Results were analyzed with one-way ANOVA and
Duncan’s multiple range test. The experiment was performed in hexaplicates. Values with different superscript letters are signiﬁcantly different, p < 0.05. ANOVA, analysis of
variance; CON, control; IBMX, 3-isobutyl-1-methylxanthine; NAC, N-acetyl cystein; ROS, reactive oxygen species.
E.-J. Koh et al / Rg1 attenuates adipocyte development 27insulin-induced terminal differentiation to adipocytes [33,34].
Furthermore, we observed that Rg1 consistently decreased the
signiﬁcant expression of NOX4 protein compared with control.
These results indicate that Rg1 preferentially repressed the
initiation of adipocyte differentiation via upregulation of endoge-
nous antioxidant enzyme and downregulation of ROS-generating
enzyme NOX4 during the early stage of adipogenesis.Fig. 4. Rg1 regulates antioxidant enzymes during early adipogenesis in 3T3-L1 cells. (A) ROS
and 25mM, 50mM, and 100mM Rg1 during 24 h and determined at 480 nm against 530 nm
experiment was performed in hexaplicates. Values with different superscript letters are sign
Western blot to analyze antioxidant enzymes and NOX4 protein expression. The experimen
dichlorodihydroﬂuoresceindiacetate; NAC, N-acetyl cystein; ND, nondifferentiated preadipo
reactive oxygen species.3.4. Effects of Rg1 on early adipogenic factor by regulating
antioxidant enzymes during early adipogenesis in 3T3-L1 cells
To gain a better understanding of the molecular mechanism
uderlying the Rg1 effect at an early stage of adipocyte differentia-
tion, we performed Western blotting to analyze the protein
expression of C/EPBb and CHOP10 in the early stage of adipogenesisproductionwas detected by DCF-DA in cells differentiated in the treatment of 5mM NAC
. Results were analyzed with one-way ANOVA and Duncan’s multiple range test. The
iﬁcantly different, p < 0.05. (B) Cell lysates differentiated during 24 h were subjected to
t was performed in triplicate. ANOVA, analysis of variance; CON, control; DCF-DA, 2,70-
cyte; NOX 4, nicotinamide adenine dinucleotide phosphate hydrogen oxidase 4; ROS,
Fig. 5. Effect of Rg1 on early adipogenic factor by regulating antioxidant enzymes during early adipogenesis in 3T3-L1 cells. (A) Cell lysates differentiated during 24 h were subjected
toWestern blot to analyze C/EBPb and CHOP10 protein expression. The experiment was performed in triplicate. (B) Cell lysates differentiated during 24 h were subjected to Western
blot to analyze GSK3b, ERK1/2, and p38 MAPK protein expression. The experiment was performed in triplicate. CHOP10, C/EBP homologous protein-10; CON, control; ERK1/2,
extracellular signal-regulated kinases 1/2; GSK3b, glycogen synthase kinase 3b; MAPK, mitogen-activated protein kinases; ND, nondifferentiated preadipocyte.
J Ginseng Res 2017;41:23e3028(Day 2). As shown in Fig. 5A and Figs. S3A, S3B, the expression of C/
EPBb at an early stage of adipocyte differentiationwith the absence
of Rg1 was increased compared to that of the undifferentiated cells.
By contrast, the cells treated with Rg1 showed a signiﬁcant
decrease in protein levels of C/EPBb at an early stage of adipocyte
adipogenesis in a dose-dependent manner. CHOP10 binds to C/
EPBb, preventing it from DNA regulatory sequence to regulate
transcription. The expression of CHOP10 was downregulated in the
early stage of adipocyte differentiation. Meanwhile, cells treated
with Rg1 in the early stage of adipocyte differentiation dramatically
attenuated the expression of CHOP10 protein in a dose-dependent
manner.
Furthermore, C/EPBb is activated by phosphorylation of MAPK
and GSK3b at the beginning of the S phase concurrent with the
translocation of GSK3b from cytosol into the nucleus in the later
stage of adipocyte differentiation [35]. To further elucidate the
molecular mechanism of the inhibitory effect of Rg1 at the early
stage of adipogenesis, we investigated the possibility of Rg1 acting
as a MAPK and GSK3b suppressor. We observed that Rg1 dere-
pressed phosphorylation of ERK1/2 and GSK3b compared with
control in a dose-dependentmanner, but not JNK1/2 and p38MAPK
repression by Rg1 in the early stage of adipocyte differentiation as
shown in Fig. 5B and Figs. S3CeS3E.
These analysis data clearly indicated that Rg1 suppresses the
early stage of gene expression cascade including CHOP10, ERK1/2,
and GSK3b, and sequentially impaired adipocyte differentiation.3.5. Rg1 supplement impair lipid accumulation in HFD-induced
obese zebraﬁsh
The afore-mentioned ﬁndings suggested that Rg1 disturbed the
lipid accumulation via regulation of the early stage of adipocyte
differentiation suppressor CHOP10 and adipogenesis cues in 3T3-
L1. To ﬁnalize the analysis of the effect of Rg1 on lipid accumula-
tion in vivo, we used HFD-induced obese zebraﬁsh that possess
structural and functional similarities with obese humans. As shown
in Fig. 6AeC, signiﬁcant increases in the fat mass and the content of
triglyceride, which was quantiﬁed by driving the ﬂuorescentintensity of Nile red staining or triglyceride measurement assay,
were evident in the diet-induced obesity (DIO) zebraﬁsh group
compared with those in the nonfat diet control (NFD) group. By
contrast, DIO zebraﬁsh treated with Rg1 showed suppressed body
fat accumulation in a dose-dependent manner. Consistent with
this, the level of triglycerides was also inhibited when the DIO
group was treated with Rg1. Hence, these results indicate that di-
etary Rg1 is beneﬁcial for suppression of fat accumulation in the
HFD-induced obese zebraﬁsh model.4. Discussion
In this study, we conducted two independent experiments to
determine whether Rg1 suppresses adipocyte differentiation in the
development of 3T3-L1 in a stage-dependent manner and fat
accumulation in HFD-induced obese zebraﬁsh.
C/EPBb, a transcriptional factor of the C/EBPa, is expressed at the
early stage of adipocyte differentiation [36] and is released by
CHOP10 as it undergoes downregulation in the early stage of
adipocyte differentiation [37]. We observed that the presence of
Rg1 attenuates early-stage-speciﬁc adipocyte differentiation via
the activation of CHOP10, which systemically suppresses adipo-
genesis cues such as C/EBPa and PPARg and stimulates the
expression of fatty acid synthase, which is essential for generating
triglyceride droplets [38,39]. We noted that fatty acid synthesis
enzymes including LPAT, Lipin1, and DGAT1 were decreased in
early-stage differentiation of 3T3-L1 treated with Rg1 compared
with control. Attenuation of both adipogenic markers and fatty acid
synthase can result in the suppression of lipid accumulation and
ROS production, which were determined using Oil Red O staining
and the NBT assay, during the early stage of differentiation of 3T3-
L1 with the presence of Rg1 compared to the intermediate and later
stages of differentiation of 3T3-L1 with the presence of Rg1. The
DCF-DA assay has also revealed that Rg1 inhibited the accumula-
tion of intracellular ROS production in a dose-dependent manner
during the early stage of differentiation of 3T3-L1 preadipocytes.
ROS-associated endogenous antioxidant enzymes such as SODs,
SOD1, and CAT convert O2e into H2O2 to prevent cytotoxicity by ROS
Fig. 6. Rg1 supplementation impairs lipid accumulation in high fat diet-induced obese Zebraﬁsh. (A) Lipid accumulation was evaluated by Nile Red staining in zebraﬁshes grown
with HFD in the presence or absence of 5mM, 10mM, 2.5mM Rg1/5mM NAC during 20 dpf and visualized under a ﬂuorescence microscope (n ¼ 3). (B) Quantiﬁcation of Nile Red
ﬂuorescence intensity. Results were analyzed by one-way ANOVA and Duncan’s multiple range test. The experiment was performed in triplicate. Values with different superscript
letters are signiﬁcantly different, p < 0.05. (C) Triglyceride was subjected to TG assay in 20 dpf zebraﬁshes grownwith HFD in the presence or absence of 5mM,10mM, 2.5mM Rg1/5mM
NAC, and measured at 540 nm. Results were analyzed by one-way ANOVA and Duncan’s multiple range test. The experiment was performed in triplicate. Values with different
superscript letters are signiﬁcantly different, p < 0.05. ANOVA, analysis of variance; CON, control; dpf, days postfertilization; NAC, N-acetyl cystein; HFD, high fat diet; ND, non-
differentiated preadipocyte; TG, triglyceride.
E.-J. Koh et al / Rg1 attenuates adipocyte development 29production. In particular, their primary mechanism to eliminate
H2O2 and lipid peroxides in the cytosol and mitochondria is cata-
lyzed by GPx, which uses glutathione to reduce H2O2 and hydro-
peroxides into water and alcohols, respectively [40,41]. We
observed that GPx, GR, SOD1, and CAT were consistently increased
in a dose-dependent manner during the early stage of differentia-
tion of 3T3-L1 preadipocytes with the presence of Rg1.
The production of ROS is released via the balance of antioxidant
and pro-oxidant enzymes. NOX4 acts as a pro-oxidant enzyme that
produces ROS levels and plays a crucial role of the electron donor
for NADPH [42]. We observed that the presence of Rg1 signiﬁcantly
decreased the gene expression of endogenous pro-oxidant enzyme
NOX4 during early-stage differentiation of 3T3-L1 preadipocytes.
The MAPK signaling pathway is ubiquitously expressed, highly
conserved GSK3b, and involved in adipocyte differentiation [43].
ERK is one of the MAPKs that have been suggested to play a role in
the development of insulin resistance and obesity [44]. We
observed that Rg1 inhibited the phosphorylation of GSK3b and ERK
stimulated during early-stage differentiation of 3T3-L1 pre-
adipocytes in a dose-dependent manner compared to control, but
not the phosphorylation of p38 MAPK.
The aforementioned evidence suggested that Rg1 attenuated
lipid accumulation via regulation of early-stage adipogenic markers
and its downstream target molecules. These results indicate that
Rg1 can repress fat accumulation in vivo. To examine whether Rg1
attenuates body fat accumulation, we used the HFD-induced
zebraﬁsh model. We observed that in HFD-induced obese zebra-
ﬁsh, levels of ﬂuorescence intensity were increased, whereas the
HFD-fed and Rg1-treated group showed signiﬁcant levels of
decrease in ﬂuorescence intensity in a dose-dependent manner.Moreover, the HFD-fed and Rg1-treated group showed reduced
triglyceride content by approximately 60% compared with control
to HFD without Rg1 treatment group. These results indicate that
Rg1 decreased the accumulation of lipids and triglycerides in HFD-
induced obese zebraﬁsh.
In conclusion, the current data demonstrate that Rg1 increases
CHOP10 during the early stage of differentiation of 3T3-L1 pre-
adipocytes, which might disrupt the multiple downstream of adi-
pogenic cascades and subsequently attenuate lipid accumulation
in vitro and in vivo. Hence, we suggest that Rg1 might have the
potential to beneﬁcially suppress body fat accumulation in the early
stage obesity.
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